Markets:

Overview

News

Currencies

International

Treasuries

Schrodinger, Inc. - Common Stock (NQ:SDGR)

16.25 -1.14 (-6.56%)

Streaming Delayed Price Updated: 4:00 PM EDT, Jun 30, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Schrodinger, Inc. - Common Stock

< Previous 1 2 3 4 5 6 7 8 9

...

14 15 Next >

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Schrödinger, Inc. - SDGR

June 25, 2025

Via ACCESS Newswire

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Schrödinger, Inc. - SDGR

June 24, 2025

Via ACCESS Newswire

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Schrödinger, Inc. - SDGR

June 23, 2025

From Pomerantz LLP

Via GlobeNewswire

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Schrödinger, Inc. - SDGR

June 20, 2025

Via ACCESS Newswire

Earnings Scheduled For May 7, 2025 ↗

May 07, 2025

Via Benzinga

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Schrödinger, Inc. - SDGR

June 18, 2025

From Pomerantz LLP

Via GlobeNewswire

Schrödinger Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)

June 17, 2025

From Schrödinger

Via Business Wire

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Schrödinger, Inc. - SDGR

June 15, 2025

From Pomerantz LLP

Via GlobeNewswire

Schrödinger Reports Encouraging Initial Phase 1 Clinical Data for SGR-1505 at EHA Annual Congress

June 12, 2025

From Schrödinger

Via Business Wire

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Schrödinger, Inc. - SDGR

June 10, 2025

From Pomerantz LLP

Via GlobeNewswire

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Schrödinger, Inc. - SDGR

June 06, 2025

From Pomerantz LLP

Via GlobeNewswire

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Schrödinger, Inc. - SDGR

June 02, 2025

From Pomerantz LLP

Via GlobeNewswire

Schrödinger Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4) to Newly Appointed Chief Commercial Officer

May 29, 2025

From Schrödinger

Via Business Wire

Schrödinger Expands Executive Leadership Team with Appointment of Mannix Aklian as Chief Commercial Officer, Global Head of Software Sales and Marketing

May 29, 2025

From Schrödinger

Via Business Wire

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Schrödinger, Inc. - SDGR

May 28, 2025

From Pomerantz LLP

Via GlobeNewswire

Schrödinger Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)

May 23, 2025

From Schrödinger

Via Business Wire

Schrödinger to Present at Jefferies Global Healthcare Conference

May 22, 2025

From Schrödinger

Via Business Wire

Schrödinger Announces CFO Appointment

May 20, 2025

From Schrödinger

Via Business Wire

Schrödinger to Present Phase 1 Clinical Data on MALT1 Inhibitor SGR-1505 at EHA Annual Congress and International Conference on Malignant Lymphoma

May 14, 2025

From Schrödinger

Via Business Wire

Schrödinger Reports Strong First Quarter 2025 Financial Results

May 07, 2025

From Schrödinger

Via Business Wire

Schrödinger to Present at BofA Securities 2025 Healthcare Conference

May 05, 2025

From Schrödinger

Via Business Wire

Schrödinger Presents New Preclinical Data at AACR Annual Meeting

April 28, 2025

From Schrödinger

Via Business Wire

Schrödinger to Announce First Quarter 2025 Financial Results on May 7

April 23, 2025

From Schrödinger

Via Business Wire

3 Momentum Stocks That Could Soar Post-Market Volatility

April 21, 2025

Three unexpected companies have rallied quickly in the period following tariff-related market turbulence; can they maintain momentum?

Via MarketBeat

Topics Artificial Intelligence World Trade

Schrödinger Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)

April 18, 2025

From Schrödinger

Via Business Wire

Schrödinger’s Statement Regarding FDA Plan to Phase Out Animal Testing Requirement for Monoclonal Antibodies and Other Drugs

April 14, 2025

From Schrödinger

Via Business Wire

Nvidia-Backed Recursion, Ginkgo Bioworks Rally Following FDA's Decision To End Animal Testing ↗

April 14, 2025

FDA announces plan to end mandatory animal testing of new drugs, replacing it with more effective and human relevant methods.

Via Benzinga

Topics Animal Testing

Fastenal Posts Better-Than-Expected Sales, Joins Simulations Plus, Certara And Other Big Stocks Moving Higher On Friday ↗

April 11, 2025

Via Benzinga

Wondering what's happening in today's after-hours session? ↗

April 10, 2025

The regular session of the US market on Thursday is now over, but let's get a preview of the after-hours session and explore the top gainers and losers driving the post-market movements.

Via Chartmill

Health Care Technology Stocks Surge After FDA Announces Plans To Phase Out Animal Testing Requirements ↗

April 10, 2025

Several stocks in the health care technology space are moving higher after the market close on Thursday after the U.S. Food and Drug Administration (FDA) announced plans to phase out animal testing...

Via Benzinga

Topics Animal Testing

< Previous 1 2 3 4 5 6 7 8 9

...

14 15 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.